  | Dupont, L.* , Noël, A.* , Colige, A.* , Joannes, L. (Other coll.), Morfoisse, F. (Other coll.), BLACHER, S. (Other coll.), Monseur, C. (Other coll.), & Deroanne, C. (Other coll.). (2022). ADAMTS2 and ADAMTS14 substitute ADAMTS3 in adults for proVEGFC activation and lymphatic homeostasis. JCI Insight. doi:10.1172/jci.insight.151509  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
  | Bekisz, S., Morfoisse, F., Noël, A., & Geris, L. (27 November 2019). Computational and mathematical lymphangiogenesis : Development of an intracellular network model in lymphatic endothelial cells [Poster presentation]. NCBME. Peer reviewed |
 | Bekisz, S., Morfoisse, F., Noël, A., & Geris, L. (May 2019). In silico lymphangiogenesis : Development of new tools to generate novel insights in the fundamental mechanisms regulating lymphangiogenesis [Poster presentation]. Conference SBHD 2019, Berlin, Germany. Peer reviewed |
 | Morfoisse, F., & Noël, A. (2019). Lymphatic and blood systems: Identical or fraternal twins? International Journal of Biochemistry and Cell Biology, 114, 105562. doi:10.1016/j.biocel.2019.105562 Peer Reviewed verified by ORBi |
 | Durré, T., Morfoisse, F., ERPICUM, C., Ebroin, M., Blacher, S., García Caballero, M., Deroanne, C., Louis, T., BALSAT, C., Van De Velde, M., Kaijalainen, S., Kridelka, F., Engelholm, L., Struman, I., Alitalo, K., Behrendt, N., Paupert, J., & Noël, A. (2018). uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications, 9 (1), 5178. doi:10.1038/s41467-018-07514-1 Peer Reviewed verified by ORBi |
 | Morfoisse, F.* , Tatin, F.* , Chaput, B., Therville, N., Vaysse, C., Métivier, R., Malloizel-Delaunay, J., Pujol, F., Godet, A.-C., De Toni, F., Boudou, F., Grenier, K., Dubuc, D., Lacazette, E., Prats, A.-C., Guillermet-Guibert, J., Lenfant, F., & Garmy-susini, B. (2018). Lymphatic Vasculature Requires Estrogen Receptor-α Signaling to Protect From Lymphedema. Arteriosclerosis, Thrombosis and Vascular Biology. doi:10.1161/ATVBAHA.118.310997 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Morfoisse, F., Durré, T., ERPICUM, C., Ebroin, M., Blacher, S., Garcia-caballero, M., Deroanne, C., Behrendt, N., Paupert, J., & Noël, A. (08 June 2017). uPARAP/endo180 receptor acts as a gatekeeper of pathological lymphangiogenesis by controlling VEGF-C driven lymphatic endothelial cell migration [Poster presentation]. Lymphatic Forum 2017, Chicago, United States - Illinois. |
Morfoisse, F. (24 April 2017). Lymphatic vasculature requires estrogen receptor alpha signaling to protect from lymphedema [Paper presentation]. 7ème Congrès de la Société Française d'Angiogenèse, toulouse, France. |
 | Morfoisse, F., Tatin, F., Hantelys, F., Adoue, A., Helfer, A.-C., Cassant-Sourdy, S., Pujol, F., Gomez-Brouchet, A., Ligat, L., Lopez, F., Pyronnet, S., Courty, J., Guillermet-Guibert, J., Marzi, S., Schneider, R. J., Prats, A.-C., & Garmy-Susini, B. H. (01 August 2016). Nucleolin Promotes Heat Shock-Associated Translation of VEGF-D to Promote Tumor Lymphangiogenesis. Cancer Research, 76 (15), 4394-405. doi:10.1158/0008-5472.CAN-15-3140 Peer Reviewed verified by ORBi |
 | Morfoisse, F., Tatin, F., Lenfant, F., Prats, A.-C., & Garmy-susini, B. (26 June 2015). Beneficial effect of estrogen on lymphatic system is inhibited by hormone therapy to promote lymphedema [Poster presentation]. 11e congrès de la Nouvelle Société Française d'Athérosclerose, Biarritz, France. |
 | Morfoisse, F., Tatin, F., Lenfant, F., Prats, A.-C., & Garmy-susini, B. (20 January 2015). Tamoxifen induces lymphatic vessels disruption and promotes lymphedema [Poster presentation]. Gordon Research Conference for Vascular Biology, Ventura, United States - California. |
 | Renaud-Gabardos, E., Hantelys, F., Morfoisse, F., Chaufour, X., Garmy-Susini, B., & Prats, A.-C. (2015). Internal ribosome entry site-based vectors for combined gene therapy. World journal of experimental medicine, 5 (1), 11-20. doi:10.5493/wjem.v5.i1.11 Peer reviewed |
 | Morfoisse, F. (17 October 2014). L'hypoxie induit l'expression du VEGF-C dans les loci métastatiques via un mécanisme traductionnel [Paper presentation]. 10e journées du Canceropôle Grand Sud Ouest, Toulouse, France. |
 | Morfoisse, F., Kuchnio, A., Frainay, C., Gomez-Brouchet, A., Delisle, M.-B., Marzi, S., Helfer, A.-C., Hantelys, F., Pujol, F., Guillermet-Guibert, J., Bousquet, C., Dewerchin, M., Pyronnet, S., Prats, A.-C., Carmeliet, P., & Garmy-susini, B. (16 January 2014). Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1a-Independent Translation-Mediated Mechanism. Cell Reports, 6, 155-167. Peer Reviewed verified by ORBi |
 | Morfoisse, F., Renaud, E., Hantelys, F., Prats, A.-C., & Garmy-Susini, B. (2014). Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis. Molecular and Cellular Oncology, 1 (1), 29907. doi:10.4161/mco.29907 Peer Reviewed verified by ORBi |
 | Morfoisse, F., Renaud, E., Hantelys, F., Prats, A.-C., & Garmy-Susini, B. (2014). Adaptation de la synthese proteique du VEGF-C par les cellules tumorales en condition hypoxique. MS. Medecine Sciences, 30 (5), 506-8. doi:10.1051/medsci/20143005010 Peer Reviewed verified by ORBi |
 | Prats, A. C., Van den Berghe, L., Rayssac, A., Ainaoui, N., Morfoisse, F., Pujol, F., Legonidec, S., Bikfalvi, A., Prats, H., Pyronnet, S., & Garmy-Susini, B. (2013). CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis. Microvascular Research, 89, 25-33. doi:10.1016/j.mvr.2013.05.005 Peer Reviewed verified by ORBi |
 | Morfoisse, F., Frainay, C., Pujol, F., Bousquet, C., Pyronnet, S., Prats, A.-C., & Garmy-susini, B. (29 October 2012). Hypoxia induces translational regulation of VEGFC [Poster presentation]. 4e congrès de la Société Française d'Angiogenèse, Monte Carlo, Monaco. |